Trial Profile
A Randomised, Double-blind, Placebo-controlled Single Dose, Dose Escalation Trial With Insulin 454 in Healthy Male Subjects, Followed by a Two-period Cross-over Trial With Insulin 454 and Insulatard in Male Subjects With Type 1 and Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Oct 2015
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin suspension isophane
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 20 Jun 2013 New trial record